NCT02706821

Anti-diabetic Effects of Persimmon Leaf Extract

An Eight-week, Randomized, Double-blind, Placebo-controlled Crossover Clinical Trial of Persimmon Leaf Extract on Anti-diabetes

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 34 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The investigators performed a 8-week, randomized, double-blind, placebo-controlled crossover human trial to evaluate the efficacy and safety of persimmon leaf extract on blood glucose. The investigators measures changes in diabetes associated parameters, including fasting blood glucose, postprandial blood glucose, insulin, C-peptide and HbA1c.

Conditions

• Prediabetes

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Persimmon leaf extract	Persimmon leaf extract (PLE), crossover design
DIETARY_SUPPLEMENT	Placebo	Placebo, crossover design

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-12-01
• Completion: 2015-02-01
• First posted: 2016-03-11
• Last updated: 2016-03-15